NEOP- I have been hesitant to post on this as I do
David Butthead the ceo has been less than truthful in the past but the drug works and the stock is cheap. They need to raise the money to get the phase 3 trials done which will cost about 10-15 million.
Both drugs could then get approval sometime in 2006. That is not a long time considering there is a potential that together they could generate several hundred million in sales.
I believe if there was a different ceo in there the trials would have been starting instead of just talking about it.
News 
Market Data 
Discover 
